Multiplexed immunosignal amplification using hybridization chain reaction-based method
US12188077B2 · kind B2 · utility
0Cited by
0References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 11, 2022 |
| Grant date | Jan 7, 2025 |
| Priority date | — |
| Expiry date | Oct 11, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/16
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The invention provides a method for optimizing isHCR for multiplexed labeling, which combines binder-biomolecule interactions with hybridization Chain Reaction (HCR).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.